Evidence map›Paper›PMID 27029380›Full record

ArticleThe protein journal2016

Altered Cytoskeleton as a Mitochondrial Decay Signature in the Retinal Pigment Epithelium.

Srinivas R Sripathi, Weilue He, O'Donnell Sylvester, Musa Neksumi, Ji-Yeon Um, Thagriki Dluya, Paul S Bernstein, Wan Jin Jahng

Open access · greenAbstract read
In one paragraph

Article in The protein journal, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Melatonin Modulates Prohibitin and Cytoskeleton in the Retinal Pigment Epithelium.International journal of scientific and engineering research · 2017
    Article
  11. Interactome Mapping Guided by Tissue-Specific Phosphorylation in Age-Related Macular Degeneration.International journal of scientific and engineering research · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 6 institutions in 3 countries.

Srinivas R SripathiDepartment of Ophthalmology, Wilmer Eye Institute, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Weilue HeDepartment of Biomedical Engineering, Michigan Technological University, Houghton, MI, USA.
O'Donnell SylvesterRetina Proteomics Laboratory, Department of Petroleum Chemistry, American University of Nigeria, Yola, Nigeria.
Musa NeksumiDepartment of Chemistry, Modibbo Adama University of Technology, Yola, Nigeria.
Ji-Yeon UmDepartment of Optometry, Seoul National University of Science and Technology, Seoul, Korea.
Thagriki DluyaDepartment of Biochemistry, Modibbo Adama University of Technology, Yola, Nigeria.
Paul S BernsteinDepartment of Ophthalmology and Visual Sciences, Moran Eye Center, University of Utah School of Medicine, Salt Lake City, UT, USA.
Wan Jin JahngRetina Proteomics Laboratory, Department of Petroleum Chemistry, American University of Nigeria, Yola, Nigeria. wan.jahng@aun.edu.ng.
American University of Nigeria · NGModibbo Adama University of Technology · NGJohns Hopkins University · USMichigan Technological University · USSeoul National University of Science and Technology · KRUniversity of Utah · US

Funding

Biochemistry and Pharmacology of the Macular CarotenoidsR01EY011600 · NEI · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI BERNSTEIN, PAUL STEVEN · 2004 to 2025
$7.7M
NEI NIH HHS R01 EY011600
6 · The paper itself

Abstract

Mitochondria mediate energy metabolism, apoptosis, and aging, while mitochondrial disruption leads to age-related diseases that include age-related macular degeneration. Descriptions of mitochondrial morphology have been non-systematic and qualitative, due to lack of knowledge on the molecular mechanism of mitochondrial dynamics. The current study analyzed mitochondrial size, shape, and position quantitatively in retinal pigment epithelial cells (RPE) using a systematic computational model to suggest mitochondrial trafficking under oxidative environment. Our previous proteomic study suggested that prohibitin is a mitochondrial decay biomarker in the RPE. The current study examined the prohibitin interactome map using immunoprecipitation data to determine the indirect signaling on cytoskeletal changes and transcriptional regulation by prohibitin. Immunocytochemistry and immunoprecipitation demonstrated that there is a positive correlation between mitochondrial changes and altered filaments as well as prohibitin interactions with kinesin and unknown proteins in the RPE. Specific cytoskeletal and nuclear protein-binding mechanisms may exist to regulate prohibitin-mediated reactions as key elements, including vimentin and p53, to control apoptosis in mitochondria and the nucleus. Prohibitin may regulate mitochondrial trafficking through unknown proteins that include 110 kDa protein with myosin head domain and 88 kDa protein with cadherin repeat domain. Altered cytoskeleton may represent a mitochondrial decay signature in the RPE. The current study suggests that mitochondrial dynamics and cytoskeletal changes are critical for controlling mitochondrial distribution and function. Further, imbalance of retrograde versus anterograde mitochondrial trafficking may initiate the pathogenic reaction in adult-onset neurodegenerative diseases.

Indexed as

Oxidative StressProtein Interaction MapsAnimalsCell LineCytoskeletonFemaleHumansMiceMitochondriaMitochondrial DynamicsProhibitinsRepressor ProteinsRetinal Pigment EpitheliumProhibitinsRepressor ProteinsCytoskeletonMitochondriaOxidative stressProhibitinProtein interactomeRetinal pigment epithelium

Identifiers

PMID27029380
PMCPMC5165655
OpenAlexW2322877040

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.